 |
FSD Pharma
HUGE
|
-1.79 |
- |
5743.5 % |
$ 69.7 M |
Canada |
 |
MorphoSys AG
MOR
|
-0.654 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.848 |
- |
1.35 % |
$ 17.8 M |
China |
 |
AgeX Therapeutics
AGE
|
-11.8 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
I-Mab
IMAB
|
-0.266 |
- |
- |
$ 866 M |
China |
 |
Compugen Ltd.
CGEN
|
6.2 |
$ 2.0 |
-0.99 % |
$ 187 M |
Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
-8.18 |
- |
- |
$ 2.18 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.68 K |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
-13.9 |
- |
-13.47 % |
$ 169 M |
France |
 |
Alpine Immune Sciences
ALPN
|
-6.14 |
- |
- |
$ 2.17 B |
USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
-28.3 |
- |
-14.27 % |
$ 1.7 M |
Singapore |
 |
AstraZeneca PLC
AZN
|
9.7 |
- |
- |
$ 96.9 B |
Britain |
 |
CureVac N.V.
CVAC
|
-4.82 |
- |
- |
$ 867 M |
Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Athira Pharma
ATHA
|
-0.0166 |
- |
- |
$ 269 M |
USA |
 |
Coherus BioSciences
CHRS
|
-1.63 |
$ 1.42 |
-0.25 % |
$ 166 M |
USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-30.2 |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
172 |
- |
- |
$ 4.9 B |
Britain |
 |
Galera Therapeutics
GRTX
|
-0.63 |
- |
-32.59 % |
$ 7.61 M |
USA |
 |
Midatech Pharma plc
MTP
|
-117 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Affimed N.V.
AFMD
|
-6.09 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
CRISPR Therapeutics AG
CRSP
|
-12.7 |
$ 51.63 |
0.28 % |
$ 4.64 B |
Schweiz |
 |
Институт стволовых клеток человека
ISKJ
|
-89 |
- |
- |
- |
Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.982 |
- |
- |
$ 231 M |
USA |
 |
Celyad Oncology SA
CYAD
|
-0.379 |
- |
- |
$ 12.5 M |
Belgium |
 |
Berkeley Lights
BLI
|
-2.46 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Celldex Therapeutics
CLDX
|
-9.67 |
$ 30.25 |
2.18 % |
$ 2.01 B |
USA |
 |
Generation Bio Co.
GBIO
|
-3.39 |
- |
- |
$ 344 M |
USA |
 |
IMV
IMV
|
-0.195 |
- |
- |
$ 13.1 M |
Canada |
 |
Akero Therapeutics
AKRO
|
-14.1 |
- |
- |
$ 3.67 B |
USA |
 |
Akouos
AKUS
|
-2.88 |
- |
0.23 % |
$ 488 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 |
- |
- |
$ 7.46 M |
Israel |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 |
- |
-4.36 % |
$ 27 M |
USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
-4.21 |
$ 0.71 |
1.92 % |
$ 32.4 M |
Israel |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-3.33 |
- |
- |
$ 384 M |
Britain |
 |
Esperion Therapeutics
ESPR
|
-42.9 |
$ 3.15 |
0.16 % |
$ 655 M |
USA |
 |
Gracell Biotechnologies
GRCL
|
-6.52 |
- |
- |
$ 3.37 B |
China |
 |
Eton Pharmaceuticals
ETON
|
53.1 |
$ 30.85 |
1.05 % |
$ 830 M |
USA |
 |
Exelixis
EXEL
|
13.2 |
$ 53.72 |
1.37 % |
$ 14.6 B |
USA |
 |
Anika Therapeutics
ANIK
|
19.1 |
$ 14.71 |
0.96 % |
$ 211 M |
USA |
 |
Advaxis
ADXS
|
-0.0633 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
-1.01 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Forte Biosciences
FBRX
|
-6.59 |
$ 17.88 |
5.18 % |
$ 232 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 |
- |
- |
$ 1.01 B |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.205 |
- |
- |
$ 26.5 M |
USA |
 |
AIkido Pharma
AIKI
|
-1.17 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 |
$ 2.96 |
- |
$ 4.87 M |
Israel |
 |
Aptose Biosciences
APTO
|
-0.0645 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Aptinyx
APTX
|
-0.159 |
- |
-39.0 % |
$ 4.57 M |
USA |